Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein tyrosine kinases in dendritic cell-mediated anti-cancer immunity. | Semin Immunol | 2026 | 42247736 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages in the progression and recurrence of meningiomas. | J Neurooncol | 2026 | 42240744 | PubTator, text mining | PubMed |
| Macrophages in colorectal cancer: Origin, function and significance of targeted therapy. | Crit Rev Oncol Hematol | 2026 | 42208630 | PubTator, text mining | PubMed |
| Association of Iba1-Positive Macrophages and B7-H3-Positive Tumor Cells with Tumor Growth Kinetics in WHO Grade II Meningioma: A Pilot Watch-and-Wait Cohort Study. | Cancers (Basel) | 2026 | 42192905 | PubTator, text mining | PubMed |
| LATS kinase activity and tumor suppressor function are regulated by a second autophosphorylation site. | J Biol Chem | 2026 | 42167578 | PubTator, text mining | PubMed |
| Tumour-derived SAA1 reprogrammes macrophages to promote CXCL1-mediated metastasis in Ovarian Cancer. | Clin Transl Med | 2026 | 42145073 | PubTator, text mining | PubMed |
| Ligandability assessment of the LAG-3 D1 domain enables discovery of a small-molecule inhibitor. | J Mol Graph Model | 2026 | 42127660 | PubTator, text mining | PubMed |
| Progress in molecular markers associated with radiotherapy efficacy in glioma. | Front Oncol | 2026 | 42125691 | PubTator, text mining | PubMed |
| Remodeling the Tumor Immune Microenvironment by Traditional Chinese Medicine: Mechanisms Focusing on TAM Polarization and CD8+ T Cell Exhaustion. | J Biochem Mol Toxicol | 2026 | 42041171 | PubTator, text mining | PubMed |
| Exosomal transfer of macrophage-derived NEAT1 enhances DNA damage response and confers cisplatin resistance in lung adenocarcinoma via the MAD1L1/p53 axis. | Int J Biol Sci | 2026 | 42003906 | PubTator, text mining | PubMed |
| Metabolic regulation of tumor-associated macrophage function and immunotherapy in cancer. | Cancer Biol Med | 2026 | 41988852 | PubTator, text mining | PubMed |
Adopting and validating a technology acceptance model-based paradigm to assess acceptance and satisfaction with electronic health information system by healthcare providers in resource-limited governmental and non-governmental hospitals. | PLOS Digit Health | 2026 | 41941445 | PubTator, text mining | PubMed |
| MLK4 orchestrates macrophage-induced triple-negative breast cancer invasion and ECM remodeling via enhanced paracrine signaling and NF-κB-MMP axis activation. | Cell Death Dis | 2026 | 41922320 | PubTator, text mining | PubMed |
| [Role of Receptor Tyrosine Kinase AXL in Cancer Targeted Therapy Drug Resistance]. | Zhongguo Fei Ai Za Zhi | 2026 | 41916916 | PubTator, text mining | PubMed |
| A stochastic programming approach for dynamic allocation of bed capacity and assignment of patients to collaborating hospitals during pandemic outbreaks. | Health Care Manag Sci | 2026 | 41910878 | PubTator, text mining | PubMed |
| Interaction between high-sensitivity C-reactive protein and mean platelet volume for 1-year major adverse cardiovascular events in stable coronary artery disease. | Sci Rep | 2026 | 41904332 | PubTator, text mining | PubMed |
| Marine Lectins in Innate Immune Modulation: Mechanistic Insights, Signaling Pathways, and a Cross-Taxa Evidence Landscape. | Mar Drugs | 2026 | 41892961 | PubTator, text mining | PubMed |
| An adaptive multi-scale spatio-temporal graph network for robust MOOC dropout prediction. | Sci Rep | 2026 | 41882070 | PubTator, text mining | PubMed |
| Efferocytosis in myocardial infarction: the regulatory core from inflammation resolution to cardiac repair. | Front Immunol | 2026 | 41878419 | PubTator, text mining | PubMed |
| GAS6 potentiates tumor progression through modulating suppressive microenvironments. | Am J Cancer Res | 2026 | 41868669 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=2